# Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis

> **NCT03722381** · — · WITHDRAWN · sponsor: **University of Michigan**

## Conditions studied

- Hemodialysis
- Pharmacokinetics

## Interventions

- **DRUG:** Amlodipine Besylate

## Key facts

- **NCT ID:** NCT03722381
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study activities were not initiated, and we do not plan to initiate them in the future.
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03722381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03722381, "Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03722381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*